VSIR and neoplasm: Research from Dr. Sam W. Lee’s group at Yale School of Medicine revealed that the in vitro inhibition of CD4+ T cells by MDSCs was reversed by treatment with antibodies targeting VISTA and in VISTA–/– syngeneic murine tumor models.